Crystallization and preliminary X-ray studies of membrane-associated Escherichia coli dihydroorotate dehydrogenase.

Dihydroorotate dehydrogenases (DHODs) are flavin-containing enzymes which catalyse the conversion of (S)-dihydroorotate to orotate, the fourth step in the de novo biosynthesis of pyrimidine nucleotides. Two major families of DHODs have now been identified based on their amino-acid sequence similarities. The two families differ in their reaction mechanisms, but structures are only known of enzymes belonging to family 1. DHOD from Escherichia coli is a typical member of family 2, which contains the membrane-associated enzymes from Gram-negative bacteria and eukaryotes. Yellow crystals grown of this enzyme belong to the space group P4(1)2(1)2 or P4(3)2(1)2. The unit-cell parameters are a = b = 119.2, c = 294.3 A. Owing to the rather large c axis, the currently available resolution of data is 2.2 A.

[1]  K. Jensen,et al.  The activity of Escherichia coli dihydroorotate dehydrogenase is dependent on a conserved loop identified by sequence homology, mutagenesis, and limited proteolysis. , 1999, Biochemistry.

[2]  K. Jensen,et al.  Active site of dihydroorotate dehydrogenase A from Lactococcus lactis investigated by chemical modification and mutagenesis. , 1997, Biochemistry.

[3]  W. Knecht,et al.  Dihydroorotate dehydrogenase. Profile of a novel target for antiproliferative and immunosuppressive drugs. , 1997, Advances in experimental medicine and biology.

[4]  K. Jensen,et al.  The B Form of Dihydroorotate Dehydrogenase from Lactococcus lactis Consists of Two Different Subunits, Encoded by the pyrDb and pyrK Genes, and Contains FMN, FAD, and [FeS] Redox Centers* , 1996, The Journal of Biological Chemistry.

[5]  P. Andersen,et al.  Sequence analysis and identification of the pyrKDbF operon from Lactococcus lactis including a novel gene, pyrK, involved in pyrimidine biosynthesis , 1996, Journal of bacteriology.

[6]  B. Kirschbaum,et al.  Functional expression of a fragment of human dihydroorotate dehydrogenase by means of the baculovirus expression vector system, and kinetic investigation of the purified recombinant enzyme. , 1996, European journal of biochemistry.

[7]  Jack Parker Davis,et al.  The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase. , 1996, Biochemistry.

[8]  P. Morand,et al.  Dihydroorotate Dehydrogenase Is a High Affinity Binding Protein for A77 1726 and Mediator of a Range of Biological Effects of the Immunomodulatory Compound (*) , 1995, The Journal of Biological Chemistry.

[9]  P. Andersen,et al.  Two different dihydroorotate dehydrogenases in Lactococcus lactis , 1994, Journal of bacteriology.

[10]  J. Navaza,et al.  AMoRe: an automated package for molecular replacement , 1994 .

[11]  R. Kirkpatrick,et al.  The dhod gene and deduced structure of mitochondrial dihydroorotate dehydrogenase in Engrailed melanogaster , 1993 .

[12]  Sung-Hou Kim,et al.  Sparse matrix sampling: a screening method for crystallization of proteins , 1991 .

[13]  K. Jensen,et al.  Nucleotide sequence of the pyrD gene of Escherichia coli and characterization of the flavoprotein dihydroorotate dehydrogenase. , 1985, European journal of biochemistry.

[14]  B. Matthews Solvent content of protein crystals. , 1968, Journal of molecular biology.

[15]  W. Bergsma-Schutter,et al.  Crystallization of Nucleic Acids and Proteins: A practical Approach , 1998 .

[16]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[17]  D. Karibian Dihydroorotate dehydrogenase (Escherichia coli). , 1978, Methods in enzymology.